Nanoparticulate Platforms for Enhancing Immunotherapy
A special issue of Nanomaterials (ISSN 2079-4991). This special issue belongs to the section "Biology and Medicines".
Deadline for manuscript submissions: closed (1 October 2022) | Viewed by 4532
Special Issue Editors
Interests: drug delivery systems; novel immunosuppressive regimens for inducing transplant tolerance; biomaterials for drug and cell delivery; targeted drug delivery for cancer treatment
Interests: mesenchymal stem cell transplantation; nanoparticle–immune cell interactions; tolerance induction; biomaterials; drug delivery
Special Issue Information
Dear Colleagues,
Immunotherapy approaches either stimulate or suppress the immune system during pathological conditions for the benefits of recipients. Recently, different immunotherapy-based nanoparticulate platforms have received significant attention for the treatment of various diseases, including cancers, autoimmune disorders, infections, and tissue or organ transplantation related rejections. Undoubtedly, nanoparticle-based immunotherapies have shown promising therapeutic outcomes in both preclinical and clinical studies.
Various types of nanoparticles have been developed to improve cancer treatment outcomes by targeting different immunological cascades to boost the immune reaction, and they have been proved to exert minimal side effects compared to conventional therapies. In infectious diseases, nanoparticles can be used to activate cellular and humoral immunity to help the body to fight against infections. In autoimmunity and transplantation settings, the immunomodulatory nanoparticles can suppress immunity and induce antigen-specific tolerance to the grafts, and thus have a great potential to abrogate the life-threatening adverse effects associated with the conventional immunosuppressive agents.
The current Special Issue invites all types of articles on nanoparticle-based approaches for immunotherapy, particularly focused on but not limited to cancer immunotherapy, autoimmune diseases, infections, and transplantation. We welcome any original articles, review papers, and communications dealing with the use of nanoparticles for immunotherapy.
Dr. Shiva Pathak
Dr. Shobha Regmi
Dr. Biki Gupta
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immunomodulatory nanoparticles
- targeted/local drug delivery
- nanoparticle–immune cell interactions
- immunotherapy for cancer diagnosis and treatment
- checkpoint inhibition for cancer treatment
- nanoparticles for autoimmune diseases and infections
- nanoparticles for promoting immune tolerance
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.